Fig. 2

Cause-specific cumulative mortality starting five years from tumor diagnosis in glioma survivors with neurofibromatosis type 1 (NF1), glioma survivors without NF1, and siblings, for causes including subsequent neoplasm, recurrent/progressive disease, cardiopulmonary causes, external causes, and other/unknown.